Email This Article

Headlines & Perspectives
Single Drugmakers Seek Rich Partners
By Adam Feuerstein
12/08/08 - 09:55 AM EST
Scores of smaller biotech firms have unpartnered drugs in the pipeline, making them ripe for alliances or takeovers.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)
Dow Jones S&P 500 NASDAQ 10-Year Note
10,452.00 1,107.93 2,201.05 36.03
Oil *
72.08
DOWN
49.05
DOWN
6.18
DOWN
11.05
UP
0.57
10 Yr
3.60%
SPDR Gold
110.21
-0.47%
-0.55%
-0.50%
+1.61%
Data delayed 20 minutes

Brokerage Partners